Warburg, me and hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

被引:361
作者
Pedersen, Peter L. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
关键词
cancer; Warburg effect; glycolysis; mitochondria; hexokinase; 2; drug target; cancer therapy; 3-bromopyruvate; positron emission tomography (PET);
D O I
10.1007/s10863-007-9094-x
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
As a new faculty member at The Johns Hopkins University, School of Medicine, the author began research on cancer in 1969 because this frequently fatal disease touched many whom he knew. He was intrigued with its viscous nature, the failure of all who studied it to find a cure, and also fascinated by the pioneering work of Otto Warburg, a biochemical legend and Nobel laureate. Warburg who died 1 year later in 1970 had shown in the 1920s that the most striking biochemical phenotype of cancers is their aberrant energy metabolism. Unlike normal tissues that derive most of their energy (ATP) by metabolizing the sugar glucose to carbon dioxide and water, a process that involves oxygen-dependent organelles called "mitochondria", Warburg showed that cancers frequently rely less on mitochondria and obtain as much as 50% of their ATP by metabolizing glucose directly to lactic acid, even in the presence of oxygen. This frequent phenotype of cancers became known as the "Warburg effect", and the author of this review strongly believed its understanding would facilitate the discovery of a cure. Following in the final footsteps of Warburg and caught in the midst of an unpleasant anti-Warburg, anti-metabolic era, the author and his students/collaborators began quietly to identify the key molecular events involved in the "Warburg effect". Here, the author describes via a series of sequential discoveries touching five decades how despite some impairment in the respiratory capacity of malignant tumors, that hexokinase 2 (HK-2), its mitochondrial receptor (VDAC), and the gene that encodes HK-2 (HK-2 gene) play the most pivotal and direct roles in the "Warburg effect". They discovered also that like a "Trojan horse" the simple lactic acid analog 3-bromopyruvate selectively enters the cells of cancerous animal tumors that exhibit the "Warburg effect" and quickly dissipates their energy (ATP) production factories (i.e., glycolysis and mitochondria) resulting in tumor destruction without harm to the animals.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 71 条
[41]   Tumor metabolism: New opportunities for cancer therapy [J].
Mérida I. ;
Ávila-Flores A. .
Clinical and Translational Oncology, 2006, 8 (10) :711-716
[42]   Mitochondria and human cancer [J].
Modica-Napolitano, Josephine S. ;
Kulawiec, Mariola ;
Singh, Keshav K. .
CURRENT MOLECULAR MEDICINE, 2007, 7 (01) :121-131
[43]  
Morris H P, 1965, Adv Cancer Res, V9, P227, DOI 10.1016/S0065-230X(08)60448-0
[44]   HEXOKINASE RECEPTOR COMPLEX IN HEPATOMA MITOCHONDRIA - EVIDENCE FROM N,N'-DICYCLOHEXYLCARBODIIMIDE-LABELING STUDIES FOR THE INVOLVEMENT OF THE PORE-FORMING PROTEIN VDAC [J].
NAKASHIMA, RA ;
MANGAN, PS ;
COLOMBINI, M ;
PEDERSEN, PL .
BIOCHEMISTRY, 1986, 25 (05) :1015-1021
[45]  
NAKASHIMA RA, 1988, CANCER RES, V48, P913
[46]   ALTERED METABOLIC STATES DO NOT CHANGE THE INTRACELLULAR-DISTRIBUTION OF HEXOKINASE IN ZAJDELA HEPATOMA ASCITES-CELLS [J].
NELSON, BD ;
KABIR, F ;
MUCHIRI, P .
BIOCHEMICAL JOURNAL, 1984, 219 (01) :159-164
[47]  
PARRY DM, 1983, J BIOL CHEM, V258, P904
[48]   Hexokinase II: The integration of energy metabolism and control of apoptosis [J].
Pastorino, JG ;
Hoek, JB .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (16) :1535-1551
[49]   Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis [J].
Pastorino, JG ;
Shulga, N ;
Hoek, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :7610-7618
[50]  
Pauser S, 1996, CANCER RES, V56, P1863